ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 1,405,000 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.54 2.2M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.54.

Evgen Pharma Share Discussion Threads

Showing 826 to 848 of 13025 messages
Chat Pages: Latest  41  40  39  38  37  36  35  34  33  32  31  30  Older
DateSubjectAuthorDiscuss
09/11/2018
17:15
Because no one is going to sell now with positive results due within a few weeks, and broker pre results fair value is £1.10 no is going to sell at 17/18p
spmc
09/11/2018
16:01
Why is there no cheap stock here ?
nico115
08/11/2018
10:17
Lots of newsflow over the next 3 or 4 months to keep the pot bubbling ..

Pre-clinical - autism, ischemic stroke, triple negative breast cancer

Phase IIs - SAH and metastatic breast cancer

pdt
08/11/2018
10:15
Last placing was smaller and went into tighter hands so see last RNSMaybe try to buy just above bid but with so little time till news I can see this gently climbing into mid 20s where I will sell half for a free ride
nico115
08/11/2018
10:03
Ooh errrr. This is going up faster than I expected. I got a few more via spreadbet yesterday but intended to buy more. So do I chase it or wait for the usual pull back.....
nobbygnome
08/11/2018
09:25
And recent placing went into sticky hands (see last RNS)Moving up on 5sBodes well
nico115
08/11/2018
09:15
The new director was for the last 4 years the MD at Torreya Partners LLC, who are leading specialists in Pharmaceutical M&A, Sales, Licensing and Capital Markets (specialising in advanced royalty sales for the latter).

Torreya have completed deals with companies like Merck (cCam Biotherapeutics for up to $605m), Gilead (Phenex Pharmaceuticals for up to $470m), Sawai (Upsher-Smith for $1.05bn) and many, many others. See www.torreya.com.

According to the RNS, the purpose of this appointment is to prepare for the commercialisation of EVG's product pipeline.

With the appointment of the former MD at Torreya Partners, EVG have just bought one of the best contact books out there, and someone trusted by big pharma. I am very impressed by their forward thinking.

sicilian_kan
08/11/2018
08:07
Just had a placing so no need for one pre results and if results are good we should get a commercial partner With a broker target at 110p this highlights how ridiculously undervalued we are and even if we aren't we ALWAYS run up prior to trial results 30p is my 4 week target
nico115
08/11/2018
07:57
She will be an expensive addition to the Salary bill
dave444
08/11/2018
07:33
The release says that her appointment is to assist with "the commercialisation of our product pipeline" They have stated before they will seek a partner to take the products forward. Good news.
pdt
08/11/2018
07:22
Yes no doubt she has been appointed for her connections, either funding or takeover
ayl30
08/11/2018
07:21
That appointment of someone experienced in fundraising means the likelihood of raising more money is increased
dave444
07/11/2018
23:10
Don’t forget pre results broker target £1.10. We should be at £2+ on positive results
spmc
07/11/2018
22:11
We went from 12p to 27p before last trial results I'm expecting a rally to 25p before the next set next month as these are more important
nico115
07/11/2018
18:11
Thanks nobby. I think today's rise could be just the start.
sicilian_kan
07/11/2018
13:56
s_k

Good to see you invested as I know you were considering it. Also I think you got a very good entry price!

nobbygnome
07/11/2018
13:18
This tested 27p before lesser results Shocked if this isn't above 20p by year end
nico115
07/11/2018
13:14
FWIW am now a holder here. The 95k trade yesterday was mine. Looked like a good double bottom and news due in next few weeks.
sicilian_kan
07/11/2018
12:58
This is about to explode, quoted 23p to buy £10,000 worth. No stock left!
spmc
07/11/2018
12:48
Good to see the price drifting up on relatively low volume. We are almost bound to see further strength ahead of the trial results at the end of the year IMHO.

Onwards and upwards!

Nobby

nobbygnome
04/11/2018
17:53
Who cares ?I asked for your help as shafted by an Aim Director and you left me in lurch So much for helping Pi vs Aim corruption.
nico115
04/11/2018
15:17
Evgen Pharma present at our growth company seminar in Manchester on the 20th November which may be of interest to shareholders or potential investors.
sharesoc
01/11/2018
06:50
I also bought stock here 200 shares I'm sure the twitter gang will get these to 20p at least ..last time 27p pre trial results !!Shop broker has a 113p from memory Strong buy Target 30p
nico115
Chat Pages: Latest  41  40  39  38  37  36  35  34  33  32  31  30  Older

Your Recent History

Delayed Upgrade Clock